Professor Qiang Pan-Hammarström Named Member of Scientific Advisory Board at CanWell

CanWell announced today that Professor Qiang Pan-Hammarström has joined the Scientific Advisory Board (SAB) at CanWell. Professor Pan-Hammarström is a leading researcher in studying the genetic mechanisms and treatment of primary immunodeficiency diseases, including B cell development, immunoglobulin gene diversity, the pathogenesis of B-cell lymphoma, and related immunotherapies. She is currently the Professor of Clinical Immunology at Karolinska Institute and the elected member of Nobel Assembly.

Professor Pan-Hammarström previously served as a visiting professor at Peking University, Sun Yat-sen University, and Rockefeller University in the United States, as well as a visiting scholar at Braeburn College and a visiting professor at Tianjin Medical University. She is currently a member of the scientific advisory committee of the KG Jebsen B-Cell Malignancy Research Center at the University of Oslo.  She also serves as an editor for Clinical Immunology, Frontiers in Immunology, and other journals, and has served as a committee member for the Swedish Research Council and the Swedish Cancer Society.